SectorChemical and pharmaceutical
Established Date--
Listing Date03/03/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees34
Fiscal Year Ends31/12
Security TypeCommon stock
Office address960 San Antonio Road Palo Alto
CA 94303
BusinessDevelops and commercializes non-opioid pain management products.
IntroductionScilex Holding Company was incorporated in Delaware in February 2019. The company is an innovative revenue generating business focused on acquiring, developing and commercializing non-opioid pain management products for acute and chronic pain. Its commercialized product portfolio includes ZTlido for post-herpetic neuralgia, ELYXYB for acute migraine, and GLOPERBA for gout attack prevention, with several product candidates in development.